Physician profile
Greg Blasko
NPI 1669479044
$1,330.51
in general payments reported to CMS, 2019-2025
13 companies · $28.80 in 2025
The $28.80 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $289 · 2021: $316 · 2022: $367 · 2024: $82.81 · 2025: $28.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $326.53 | 2020-2022 | |
| Smith+Nephew, INC. | $220.72 | 2020-2024 | Pico |
| Horizon Therapeutics Plc | $216.44 | 2019-2022 | |
| Integra Lifesciences Corporation | $107.20 | 2021 | |
| Misonix INC | $105.81 | 2020 | |
| Kerecis Limited | $101.81 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $85.90 | 2019 | |
| 3m Company | $55.25 | 2019 | |
| Medtronic, INC. | $40.89 | 2024 | Intellis Adaptivestim |
| Fusion Orthopedics USA, LLC | $28.80 | 2025 | |
| Anika Therapeutics, INC. | $16.40 | 2022 | |
| Aroa Biosurgery Incorporated | $12.78 | 2022 | |
| Merck Sharp & Dohme LLC | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Blasko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.